Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2015-07, Vol.192 (1), p.117-118
Hauptverfasser:	Bastard, Mathieu, Bonnet, Maryline, du Cros, Philipp, Khamraev, Atadjan Karimovich, Hayrapetyan, Armen, Kimenye, Kamene, Khurkhumal, Shazina, Dlamini, Themba, Telnov, Alex, Sanchez-Padilla, Elisabeth, Hewison, Cathy, Varaine, Francis
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Female Humans Male Microbial Sensitivity Tests Mycobacterium tuberculosis - drug effects Tuberculosis, Multidrug-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	118
container_issue	1
container_start_page	117
container_title	American journal of respiratory and critical care medicine
container_volume	192
creator	Bastard, Mathieu Bonnet, Maryline du Cros, Philipp Khamraev, Atadjan Karimovich Hayrapetyan, Armen Kimenye, Kamene Khurkhumal, Shazina Dlamini, Themba Telnov, Alex Sanchez-Padilla, Elisabeth Hewison, Cathy Varaine, Francis
description
doi_str_mv	10.1164/rccm.201504-0747LE
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1693707059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1693707059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c996-d3e8b3e69db01fb29f12d8eac8a8fd1bcae08865d58b958509eb4045ac093dfb3</originalsourceid><addsrcrecordid>eNo9kMFOwzAQRC0EoqXwAxyQj1xS1nGc2FwQKoUiFYqqHrhFtrOBoKQudiLUvydVC6cdjWZGq0fIJYMxY2ly461txjEwAUkEWZLNp0dkyAQXUaIyOO41ZDxKEvU-IGchfAGwWDI4JYM4ZZwplQ5JtcRNvb2lM_dDHxxtP5G-Yi-xrNZVW7l1oKXz9KWr26rw3Ue0xFCFVq9buuoMetvVrjfoyqNuG-ztRdda12CgS9R1vaVv6PuF5u6cnJS6DnhxuCOyepyuJrNovnh6ntzPI9s_FBUcpeGYqsIAK02sShYXErWVWpYFM1YjSJmKQkijhBSg0CSQCG1B8aI0fESu97Mb7747DG3eVMFiXes1ui7kLFU8gwyE6qPxPmq9C8FjmW981Wi_zRnkO8L5jnC-J5zvCfelq8N-Zxos_it_SPkvfGl52w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693707059</pqid></control><display><type>article</type><title>Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>American Thoracic Society (ATS) Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bastard, Mathieu ; Bonnet, Maryline ; du Cros, Philipp ; Khamraev, Atadjan Karimovich ; Hayrapetyan, Armen ; Kimenye, Kamene ; Khurkhumal, Shazina ; Dlamini, Themba ; Telnov, Alex ; Sanchez-Padilla, Elisabeth ; Hewison, Cathy ; Varaine, Francis</creator><creatorcontrib>Bastard, Mathieu ; Bonnet, Maryline ; du Cros, Philipp ; Khamraev, Atadjan Karimovich ; Hayrapetyan, Armen ; Kimenye, Kamene ; Khurkhumal, Shazina ; Dlamini, Themba ; Telnov, Alex ; Sanchez-Padilla, Elisabeth ; Hewison, Cathy ; Varaine, Francis</creatorcontrib><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.201504-0747LE</identifier><identifier>PMID: 26131996</identifier><language>eng</language><publisher>United States</publisher><subject>Antitubercular Agents - therapeutic use ; Female ; Humans ; Male ; Microbial Sensitivity Tests ; Mycobacterium tuberculosis - drug effects ; Tuberculosis, Multidrug-Resistant - drug therapy</subject><ispartof>American journal of respiratory and critical care medicine, 2015-07, Vol.192 (1), p.117-118</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c996-d3e8b3e69db01fb29f12d8eac8a8fd1bcae08865d58b958509eb4045ac093dfb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4026,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26131996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bastard, Mathieu</creatorcontrib><creatorcontrib>Bonnet, Maryline</creatorcontrib><creatorcontrib>du Cros, Philipp</creatorcontrib><creatorcontrib>Khamraev, Atadjan Karimovich</creatorcontrib><creatorcontrib>Hayrapetyan, Armen</creatorcontrib><creatorcontrib>Kimenye, Kamene</creatorcontrib><creatorcontrib>Khurkhumal, Shazina</creatorcontrib><creatorcontrib>Dlamini, Themba</creatorcontrib><creatorcontrib>Telnov, Alex</creatorcontrib><creatorcontrib>Sanchez-Padilla, Elisabeth</creatorcontrib><creatorcontrib>Hewison, Cathy</creatorcontrib><creatorcontrib>Varaine, Francis</creatorcontrib><title>Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><subject>Antitubercular Agents - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Tuberculosis, Multidrug-Resistant - drug therapy</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMFOwzAQRC0EoqXwAxyQj1xS1nGc2FwQKoUiFYqqHrhFtrOBoKQudiLUvydVC6cdjWZGq0fIJYMxY2ly461txjEwAUkEWZLNp0dkyAQXUaIyOO41ZDxKEvU-IGchfAGwWDI4JYM4ZZwplQ5JtcRNvb2lM_dDHxxtP5G-Yi-xrNZVW7l1oKXz9KWr26rw3Ue0xFCFVq9buuoMetvVrjfoyqNuG-ztRdda12CgS9R1vaVv6PuF5u6cnJS6DnhxuCOyepyuJrNovnh6ntzPI9s_FBUcpeGYqsIAK02sShYXErWVWpYFM1YjSJmKQkijhBSg0CSQCG1B8aI0fESu97Mb7747DG3eVMFiXes1ui7kLFU8gwyE6qPxPmq9C8FjmW981Wi_zRnkO8L5jnC-J5zvCfelq8N-Zxos_it_SPkvfGl52w</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Bastard, Mathieu</creator><creator>Bonnet, Maryline</creator><creator>du Cros, Philipp</creator><creator>Khamraev, Atadjan Karimovich</creator><creator>Hayrapetyan, Armen</creator><creator>Kimenye, Kamene</creator><creator>Khurkhumal, Shazina</creator><creator>Dlamini, Themba</creator><creator>Telnov, Alex</creator><creator>Sanchez-Padilla, Elisabeth</creator><creator>Hewison, Cathy</creator><creator>Varaine, Francis</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?</title><author>Bastard, Mathieu ; Bonnet, Maryline ; du Cros, Philipp ; Khamraev, Atadjan Karimovich ; Hayrapetyan, Armen ; Kimenye, Kamene ; Khurkhumal, Shazina ; Dlamini, Themba ; Telnov, Alex ; Sanchez-Padilla, Elisabeth ; Hewison, Cathy ; Varaine, Francis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c996-d3e8b3e69db01fb29f12d8eac8a8fd1bcae08865d58b958509eb4045ac093dfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antitubercular Agents - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Tuberculosis, Multidrug-Resistant - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bastard, Mathieu</creatorcontrib><creatorcontrib>Bonnet, Maryline</creatorcontrib><creatorcontrib>du Cros, Philipp</creatorcontrib><creatorcontrib>Khamraev, Atadjan Karimovich</creatorcontrib><creatorcontrib>Hayrapetyan, Armen</creatorcontrib><creatorcontrib>Kimenye, Kamene</creatorcontrib><creatorcontrib>Khurkhumal, Shazina</creatorcontrib><creatorcontrib>Dlamini, Themba</creatorcontrib><creatorcontrib>Telnov, Alex</creatorcontrib><creatorcontrib>Sanchez-Padilla, Elisabeth</creatorcontrib><creatorcontrib>Hewison, Cathy</creatorcontrib><creatorcontrib>Varaine, Francis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bastard, Mathieu</au><au>Bonnet, Maryline</au><au>du Cros, Philipp</au><au>Khamraev, Atadjan Karimovich</au><au>Hayrapetyan, Armen</au><au>Kimenye, Kamene</au><au>Khurkhumal, Shazina</au><au>Dlamini, Themba</au><au>Telnov, Alex</au><au>Sanchez-Padilla, Elisabeth</au><au>Hewison, Cathy</au><au>Varaine, Francis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>192</volume><issue>1</issue><spage>117</spage><epage>118</epage><pages>117-118</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><cop>United States</cop><pmid>26131996</pmid><doi>10.1164/rccm.201504-0747LE</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1073-449X
ispartof	American journal of respiratory and critical care medicine, 2015-07, Vol.192 (1), p.117-118
issn	1073-449X 1535-4970
language	eng
recordid	cdi_proquest_miscellaneous_1693707059
source	MEDLINE; Journals@Ovid Complete; American Thoracic Society (ATS) Journals Online; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Antitubercular Agents - therapeutic use Female Humans Male Microbial Sensitivity Tests Mycobacterium tuberculosis - drug effects Tuberculosis, Multidrug-Resistant - drug therapy
title	Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T23%3A54%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply:%20How%20Do%20the%20New%20Definitions%20for%20Multidrug-Resistant%20Tuberculosis%20Treatment%20Outcomes%20Really%20Perform?&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Bastard,%20Mathieu&rft.date=2015-07-01&rft.volume=192&rft.issue=1&rft.spage=117&rft.epage=118&rft.pages=117-118&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.201504-0747LE&rft_dat=%3Cproquest_cross%3E1693707059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693707059&rft_id=info:pmid/26131996&rfr_iscdi=true